Zealand Pharma Expands Beyond Peptides in $1.2 Billion Generate Collaboration

Collaboration will combine Zealand Pharma’s expertise in metabolic health with Generate’s proprietary generative AI platform to create multis...

October 15, 2026 | Thursday | News
GCCL and LabConnect Expand Clinical Trial Collaboration Across APAC and North America

GCCL, a South Korea-based leading global clinical trial central laboratory represented by CEO Kwan-goo Cho, announced that it signed a Memorandum of Unders...

October 14, 2026 | Wednesday | News
Andelyn Biosciences and PQP Group Partner on EU and UK Gene Therapy Supply

Andelyn Biosciences (“Andelyn”), a leading US-based patient-focused cell and gene therapy Contract Development and Manufacturing Organization (...

October 09, 2026 | Friday | News
Axplora Advances Axotecan to Establish European Exatecan Supply for ADC Developers

Independent European source of exatecan will expand choice and strengthen supply resilience for ADC developers Gram-scale material available, with...

October 08, 2026 | Thursday | News
Italfarmaco and VeriSIM Life Partner to Develop Novel HDAC-Targeted Therapies

Strategic collaboration combines Italfarmaco’s leadership in HDAC biology and therapeutic development with VeriSIM Life’s Mechanistic AI dr...

October 07, 2026 | Wednesday | News
CSL and Alentis Partner to Develop Lixudebart for Rare Kidney and Liver Diseases

CSL and Alentis Therapeutics announced they have entered into an exclusive global collaboration agreement to co-develop and co-promote lixudebart, which ha...

October 06, 2026 | Tuesday | News
Lonza and Asimov Partner to Advance Lentiviral Vector Manufacturing for In Vivo Therapies

Collaboration connects Asimov’s genetic design and cell line technologies with Lonza’s process development, scale-up and GMP manufacturin...

October 05, 2026 | Monday | News
Daiichi Sankyo, AstraZeneca and Summit Partner to Evaluate Datroway and Ivonescimab in Cancer

Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/NYSE: AZN) have entered into a clinical trial collaboration agreement with Summit Therapeutics Inc. (Na...

October 05, 2026 | Monday | News
Curaleaf and Jupiter Research Launch QMID Medical Cannabis Inhalation Device in Australia

Curaleaf International, part of Curaleaf Holdings, Inc. (TSX: CURA) in partnership with Jupiter Research LLC, announced that its Que Medical Inhalation Dev...

October 05, 2026 | Monday | News
Replimune Launches TUDRIQEV in US for Advanced Melanoma Following FDA Approval

Replimune Group, Inc. (NASDAQ: REPL), a commercial stage biotechnology company pioneering the development of novel oncolytic immunotherapies, announced tha...

October 05, 2026 | Monday | News
Rakovina Therapeutics and Celvion Partner to Advance AI-Driven Precision Cancer Therapies

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (OTCMKTS: RKVTF) a biopharmaceutical company advancing innovative cancer therapies through AI-powered d...

October 02, 2026 | Friday | News
Quotient Sciences and Acesion Pharma Collaborate on AI-Enhanced Formulation Development

  Quotient Sciences, a global integrated CRDMO (contract research, development and manufacturing organization), and Acesion Pharma, a Copenhagen-base...

September 30, 2026 | Wednesday | News
Sun Nuclear Validates AdaptCHECK for Siemens Healthineers’ Accela Adaptive Radiotherapy System

Sun Nuclear, a Mirion Medical company, announced that its AdaptCHECK™ software has been validated in collaboration with Siemens Healthineers technica...

September 29, 2026 | Tuesday | News
Grünenthal and DKSH Expand Asia-Pacific Partnership to Broaden Access to Pain Medicines

Grünenthal, a global leader in pain management and research, and DKSH Business Unit Healthcare, a strategic healthcare business partner and leading pr...

September 29, 2026 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close